Enact Fund has successfully acquired GEO Specialty Chemicals UK Ltd., aiming to leverage its growth potential in the specialty chemicals market.
Target Information
The Enact Fund, under the management of the private equity firm Endless, has recently acquired GEO Specialty Chemicals UK Ltd. ("GEO"), a manufacturer of specialty chemicals based in Southampton. This acquisition follows a period of significant activity for the fund, including strategic exits from Realise Training Group and Greenray Turbine Solutions.
GEO operates on a 53-acre site and features two distinct business units that possess global-scale capabilities and advanced expertise in alkoxylation, methacrylate chemistry, and specialty silicones. The company caters to premium markets, such as coatings, lubricants, and medical devices, achieving annual revenues of approximately £68 million. GEO has earned a reputation for high-quality products, exceptional service, and a focus on new product development, with its operational legacy dating back to the 1950s.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The specialty chemicals industry in the UK is characterized by innovation and adaptability, responding effectively to the demands of niche markets. With a robust focus on sustainability and efficiency, companies like GEO are positioned to ca
Similar Deals
Phenna Group → Construction Testing Services
2025
Enact Fund
invested in
GEO Specialty Chemicals UK Ltd.
in 2026
in a Buyout deal
Disclosed details
Revenue: $85M